EFFICACY OF ORAL GRANISETRON IN UREMIC PRURITUS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

LAYEGH POURAN; MOJAHEDIN M.J.; EMAM GHOLI TABAR MALEK SHAH P.; SHARIFIPOUR FARZANEH; VAHEDIAN MOHAMMAD; NAZEMIAN F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2007 | Volume:10 | Issue:1 (39) Page(s): 20-25

Download Full-Text

Persian Verion

View:

1,384

Download:

Cites:

Information Journal Paper

Title

EFFICACY OF ORAL GRANISETRON IN UREMIC PRURITUS

Author(s)

Keywords

GRANISETRONQ3

HEMODIALYSISQ3

PERITONEAL DIALYSISQ3

PRURITUSQ2

Abstract

Background and aim: Uremic PRURITUS is a relatively common and distressing problem for patients with chronic renal failure. Serotonin and histamine have been reported as possible mediators of uremic PRURITUS. GRANISETRON, a potent and selective inhibitor of 5-HT3 receptors was developed for relief of chemotherapy induced nausea. There are some studies about effect of Ondansetron in uremic PRURITUS and recently one case report described relief of renal itch with GRANISETRON. The aim of our study was to evaluate the effect of GRANISETRON on uremic PRURITUS in patients with chronic renal failure under dialysis.Materials and methods: 14 uremic patients under HEMODIALYSIS with moderate and severe PRURITUS were enrolled in this open trial. Patients received GRANISETRON tablet (1 mg twice a day) for 1 month. Patients were asked to complete a questionnaire assessing the severity of PRURITUS on twice a day.Results: 77% of the patients responded to the treatment and on the 1st, 2nd and 4th weeks of treatment, the mean values of PRURITUS score were 23 (range 11-40), 16(range 8-35), 8(range 0-35) points, respectively, while at baseline (before treatment) it was 31 (range 20-35) points (p=0.03). PRURITUS disappeared in 7 patients at the end of 4th week, and was mild in 3 others. This effect was maintained during the study. Weekly clinical and laboratory examinations showed no side effects.Conclusion: GRANISETRON may be an effective, safe and well tolerated drug for the treatment of uremic PRURITUS in HEMODIALYSIS patients.

Cites

No record.

References

No record.

Cite

APA: Copy

LAYEGH, POURAN, MOJAHEDIN, M.J., EMAM GHOLI TABAR MALEK SHAH, P., SHARIFIPOUR, FARZANEH, VAHEDIAN, MOHAMMAD, & NAZEMIAN, F.. (2007). EFFICACY OF ORAL GRANISETRON IN UREMIC PRURITUS. IRANIAN JOURNAL OF DERMATOLOGY, 10(1 (39)), 20-25. SID. https://sid.ir/paper/57981/en

Vancouver: Copy

LAYEGH POURAN, MOJAHEDIN M.J., EMAM GHOLI TABAR MALEK SHAH P., SHARIFIPOUR FARZANEH, VAHEDIAN MOHAMMAD, NAZEMIAN F.. EFFICACY OF ORAL GRANISETRON IN UREMIC PRURITUS. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2007;10(1 (39)):20-25. Available from: https://sid.ir/paper/57981/en

IEEE: Copy

POURAN LAYEGH, M.J. MOJAHEDIN, P. EMAM GHOLI TABAR MALEK SHAH, FARZANEH SHARIFIPOUR, MOHAMMAD VAHEDIAN, and F. NAZEMIAN, “EFFICACY OF ORAL GRANISETRON IN UREMIC PRURITUS,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 10, no. 1 (39), pp. 20–25, 2007, [Online]. Available: https://sid.ir/paper/57981/en

Related Journal Papers